INVO Fertility (IVF) Gross Margin (2011 - 2026)
INVO Fertility's (IVF) quarterly Gross Margin came in at 36.37% in Q1 2026, down 5.0% year-on-year from 38.29% in Q1 2025, and up 1.55% on a QoQ basis from 35.82% in Q3 2025.
INVO Fertility (IVF) Gross Margin (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has 16 years of Gross Margin data on file, last reported at 36.37% in Q1 2026.
- On a quarterly basis, Gross Margin fell 5.0% year-over-year to 36.37% in Q1 2026; TTM through Mar 2026 was 37.52%, a 411.0% decrease from a year earlier, with the FY2024 full-year figure at 44.0%, up 804.0% from the prior year.
- Gross Margin for Q1 2026 stood at 36.37%, up from 35.82% in the prior quarter.
- Over the last five years, Gross Margin for IVF reached as high as 79.15% in Q1 2023 and fell as low as 25.38% in Q2 2023.
- Historically, Gross Margin has averaged 45.98% across 5 years, with a median of 42.27% in 2025.
- Across the five-year window, Gross Margin sank 4655 bps in 2022 and jumped 2770 bps in 2024, its largest moves.
- Year by year, Gross Margin stood at 71.53% in 2022, then sank by 50 bps to 35.82% in 2023, then rose by 21 bps to 43.21% in 2024, then decreased by 17 bps to 35.82% in 2025, then advanced by 2 bps to 36.37% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 36.37% in Q1 2026, 35.82% in Q3 2025, and 41.32% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | 36.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.37% |
| Sep 30, 2025 | 35.82% |
| Jun 30, 2025 | 41.32% |
| Mar 31, 2025 | 36.42% |
| Dec 31, 2024 | 43.21% |
| Sep 30, 2024 | 31.03% |
| Jun 30, 2024 | 53.08% |
| Mar 31, 2024 | 46.06% |
| Dec 31, 2023 | 35.82% |
| Sep 30, 2023 | 40.41% |
| Jun 30, 2023 | 25.38% |
| Mar 31, 2023 | 79.15% |
| Dec 31, 2022 | 71.53% |
| Sep 30, 2022 | 53.63% |
| Jun 30, 2022 | 46.45% |
| Mar 31, 2022 | 60.05% |
| Dec 31, 2021 | 98.45% |
| Sep 30, 2021 | 90.67% |
| Jun 30, 2021 | 93.00% |
| Mar 31, 2021 | 90.83% |